NuVasive Investor Relations

NuVasive is a world leader in minimally invasive, procedurally integrated spine solutions. From complex spinal deformity to degenerative spinal conditions, NuVasive is transforming spine surgery with innovative technologies designed to deliver reproducible and clinically proven surgical outcomes.

Analyst Coverage

Firm Analyst
Bank of America / Merrill Lynch
Bob Hopkins
Ryan Zimmerman
Canaccord Genuity
Kyle Rose
Joanne Wuensch
Cowen and Company
Josh Jennings, MD
Credit Suisse
Matt Miksic
Jefferies & Company, Inc.
Anthony Petrone
JMP Securities
David Turkaly
JP Morgan
Allen Gong
Loop Capital Markets
Jason Wittes
Morgan Stanley
Drew Ranieri
Needham and Company
Mike Matson
Piper Sandler
Matthew O’Brien
Robert W. Baird & Co.
Jeff D. Johnson
Stifel Nicolaus
Mathew Blackman
Sam Brodovsky
Matt Taylor

Nuvasive Inc is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Nuvasive Inc's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Nuvasive Inc or its management. Nuvasive Inc does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.